Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/AB3A stock hub

FRA/AB3A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/AB3Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/AB3AFRA/AB3A

—

Loading chart…

In the news

Latest news · FRA/AB3A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.2

P25 n/aP50 n/aP75 n/a

Trailing P/E31.7

P25 n/aP50 n/aP75 n/a

ROE4.9

P25 n/aP50 n/aP75 n/a

ROIC0.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/AB3A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	835
Employees Change	58%
Employees Change Percent	4.41
Enterprise value	EUR 2.1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.8B
Price	EUR 17.58
Price currency	EUR
Rev Per Employee	2,268,673.99x
Sic	2836
Symbol	fra/AB3A
Website	https://www.sarepta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.15%
EV Earnings	37.65x
EV/EBITDA	12.3x
EV/FCF	21.32x
EV/Sales	1.14x
FCF yield	5.57%
Forward P/E	8.2x
P/B ratio	1.37x
P/E ratio	31.72x
P/S ratio	0.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.05%
EBITDA Margin	2.11%
FCF margin	5.26%
Gross margin	-6.49%
Gross Profit	EUR -122.9M
Gross Profit Growth Q	3.69%
Net Income	EUR 56.4M
Pretax Margin	1.12%
Profit Margin	2.98%
Profit Per Employee	EUR 67,574
ROA	0.02
Roa5y	-6.49
ROCE	0.04
ROE	4.91
Roe5y	-55.33
ROIC	0.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.6%
Cagr15y	6.66%
Cagr1y	-46.43%
Cagr3y	-46.93%
Cagr5y	-22.15%
Revenue Growth	-2.2x
Revenue Growth Q	-1.89x
Revenue Growth3 Y	30.82x
Revenue Growth5 Y	30.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.66
Assets	EUR 2.8B
Cash	EUR 566.5M
Current Assets	EUR 2B
Current Liabilities	EUR 423.3M
Debt	EUR 908.1M
Debt EBITDA	EUR 5.15
Debt Equity	EUR 0.7
Debt FCF	EUR 9.11
Equity	EUR 1.3B
Interest Coverage	0.02
Liabilities	EUR 1.5B
Long Term Assets	EUR 798.4M
Long Term Liabilities	EUR 1B
Net Cash	EUR -341.6M
Net Cash By Market Cap	EUR -19.08
Net Debt EBITDA	EUR 8.53
Net Debt Equity	EUR 0.26
Net Debt FCF	EUR 3.43
Tangible Book Value	EUR 1.3B
Tangible Book Value Per Share	EUR 12.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.63
Inventory Turnover	2.39
Net Working Capital	EUR 1B
Quick ratio	2.41
Working Capital	EUR 1.6B
Working Capital Turnover	EUR 1.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	17.2%
1Y total return	-46.4%
200-day SMA	16.79
3Y total return	-85.06%
50-day SMA	16.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.41%
All Time High	160.1
All Time High Change	-89.02%
All Time High Date	2024-06-21
All Time Low	2.26
All Time Low Change	677.19%
All Time Low Date	2011-12-20
ATR	0.58
Ch YTD	-4.12
High	17.58
High52	37.9
High52 Date	2025-06-09
High52ch	-53.61%
Low	17.58
Low52	8.96
Low52 Date	2025-07-24
Low52ch	96.16%
Ma50ch	5.03%
Price vs 200-day SMA	4.73%
RSI	49.51
RSI Monthly	31.72
RSI Weekly	46.7
Sharpe ratio	-0.06x
Sortino ratio	-0.03
Total Return	-10.78%
Tr YTD	-4.12
Tr15y	163.02%
Tr1m	-9.38%
Tr1w	-2.98%
Tr3m	23.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 908,063
Operating margin	0.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93,469,779%
Net Borrowing	-135,146,487.6
Shares Insiders	4.12%
Shares Institutions	82.27%
Shares Qo Q	16.34%
Shares Yo Y	10.78%
Short Ratio	8.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 3M
Average Volume	33.95x
Bv Per Share	12.36
CAPEX	EUR -52.4M
Ch10y	17.2
Ch15y	163
Ch1m	-9.38
Ch1w	-2.98
Ch1y	-46.4
Ch3m	23.2
Ch3y	-85.06
Ch5y	-71.41
Ch6m	16.23
Change	1.27%
Change From Open	0
Close	17.36
Days Gap	1.27
Depreciation Amortization	38,274,460.8
Earnings Date	2026-05-06
EBIT	EUR 908,063
EBITDA	EUR 40.1M
EPS	EUR 0.55
F Score	6
FCF	EUR 99.6M
FCF EV Yield	4.69x
Financing CF	-156,611,830
Fiscal Year End	December
Founded	1,980
Graham Number	12.64379
Graham Upside	-28.08
Income Tax	EUR -35.2M
Investing CF	196,381,004
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2012-07-12
Last Split Type	Reverse
Ma150	17.32
Ma150ch	1.5%
Ma20	17.89
Ma20ch	-1.72%
Net CF	191,785,182
Open	17.58
P FCF Ratio	17.97
P OCF Ratio	11.77
Ppne	390,316,908.6
Price Date	2026-05-08
Price EBITDA	EUR 44.69
Ptbv Ratio	1.4
Relative Volume	71.14x
Revenue	1,894,342,783x
SBC By Revenue	5.1x
Share Based Comp	96,588,599
Tax By Revenue	-1.86x
Tr6m	16.23%
Volume	0
Z Score	0.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/AB3A pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/AB3A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/AB3A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.3%

Share of float held by funds and institutions

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/AB3A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.5

Neutral momentum band

Price vs 200-day MA

+4.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/AB3A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/AB3A stock rating?

fra/AB3A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/AB3A analysis?

The full report lives at /stocks/fra/AB3A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/AB3A?

The latest report frames fra/AB3A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/AB3A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.